Abstract
Objective:Hypertension (HTN) is the leading risk factor for cardiovascular mortality globally. Numerous studies have compared safety and efficacy between antihypertensive classes, but in-class comparisons of angiotensin II receptor blockers (ARBs) in fixed-dose combinations (FDC) with a calcium chan
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
